Charles Bennett to Anti-HIV Agents
This is a "connection" page, showing publications Charles Bennett has written about Anti-HIV Agents.
Connection Strength
1.431
-
Single- versus multiple-tablet HIV regimens: adherence and hospitalization risks. Am J Manag Care. 2016 04; 22(4):242-8.
Score: 0.456
-
Adverse drug interactions: moving from perception to action. Pharmacoeconomics. 2010; 28(1):19-22.
Score: 0.296
-
Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr. 2004 Feb 01; 35(2):120-5.
Score: 0.196
-
Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen. Ann Intern Med. 2002 Jul 16; 137(2):146-7.
Score: 0.176
-
A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. Am J Respir Crit Care Med. 2000 Apr; 161(4 Pt 1):1081-6.
Score: 0.151
-
Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project. Drug Saf. 2009; 32(2):147-58.
Score: 0.069
-
HIV and AIDS: an overview. Nurs Stand. 2001 Feb 28-Mar 6; 15(24):45-52; quiz 54-5.
Score: 0.040
-
Gender differences in care for acquired immunodeficiency syndrome-related Pneumocystis carinii pneumonia. Womens Health Issues. 1998 Jan-Feb; 8(1):45-52.
Score: 0.032
-
Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns. 2007 Feb; 65(2):253-60.
Score: 0.015